Introduction
Acute diarrhea Traditional medicine and herbal are two of Acute lymphoblastic leukemia (ALL) is the most common cancer in children and adolescents with more than 3,000 new cases each year. The American Cancer Society (2017), estimates there are 5,970 new cases of ALL in adults and children consisting of 3,350 men and 2,620 women. An estimated 1,440 deaths from this disease (800 in men and 640 in women). The National Cancer Institute estimates that in 2018 as many as 60,300 people will live with ALL. 1 The highest ALL incidence is in children aged 2-5 years with an average incidence of 4-4.5 cases/year/ 100,000 children under 15 years of age.
The FAB system defines three categories of lymphoblasts. L1 lymphoblasts are usually smaller, with scant cytoplasm and inconspicuous nucleoli. Cells of the L2 variety are larger, and they demonstrate considerable heterogeneity in size, prominent nucleoli, and more abundant cytoplasm. Lymphoblasts of the L3 type, notable for their deep cytoplasmic basophilia, are large, frequently display prominent cytoplasmic vacuolation, and are morphologically identical to Burkitt's lymphoma cells. 2 ALL is a neoplastic disease as a result of somatic mutations in several stages in a lymphoid progenitor cell in one of several stages of development. 3 Males have a worse prognosis than female. 4 The Academy of Sciences reported a fivefold increase in cancer risk was found in children exposed to radiation in the first trimester. Other factors studied which are the possible causes of ALL include parents who smoke, use of herbicides and pesticides, the military experience of parents where they are susceptible to chemicals, alcohol use, maternal Several studies have shown that the incidence of malnutrition in children who patient from ALL tends to increase threefold compared to children who are healthy/ have no history of cancer.
5 ALL accounts about 80% of leukemia cases in children, it is important to conduct scientific research to improve understanding of the epidemiology, signs and symptoms, prognostic factor, hence children with ALL can be immediately detected and treated.
Methods
This research used the descriptive study by using medical data record of patients with ALL at Department of Pediatrics Dr. Soetomo Hospital Surabaya from January-December 2016 using total sampling. The inclusion criteria of this study were all patients aged 0-18 years old who were first diagnosed as ALL and have complete medical record data, while incomplete medical record data were excluded. We collected data regarding gender, age, family history of leukemia, initial nutritional status using the WHO 2005 chart (body weight/height) for 0-5 years and CDC 2000 curve for ages > 5 years, clinical symptoms and signs, laboratory assessment, description of cell morphology of hospital examination based on FAB (French-America-British). We determined risk classification based on age, initial leukocyte count, central nervous system status, and outcomes. All data collected presented as descriptive analysis.
Results
From a total of 216 patients with ALL in 2016, 50 data met the inclusion criteria. The number of exclusion data was 114 medical documents, 132 patients underwent therapy, 11 people ALL relapsed, 4 people with a diagnosis, and 33 data were incomplete, data the remaining data was not found in the medical record archive.
Within one year there were 50 new patients diagnosed with ALL, 27 people (54%) including male and the remaining 23 people (46%) female, with a ratio of 1.17. The average age of the patient at the time of initial diagnosis is 6.5 years of age, with the youngest age being 1 year while the oldest age is 17 years. Most patient families (84%) do not have a history of leukemia. However, one patient showed a history of leukemia in his twin brother. Children with malnutrition as many as 21 people (42%) were found most at diagnosis.
While the remaining 20 patients (40%) with adequate nutrition, 8 patients (16%) with overnutrition, and 1 patient (2%) with no data. Based on risk classification, the average patient was included in the standard risk with as many as 27 people (54%) while the rest were 23 people with high risk (46%). The cell morphology based on FAB was obtained, lymphoblasts L1 (68%) were small in size with little cytoplasm; in L2 cells (18%) larger and pleomorphic with multiple cytoplasm, irregular core shape, and real nuclei; and L3 cells (0%) have fine spotted homogeneous core chromatin, clear nuclei, and dark blue cytoplasm with real vacuoles. Although the FAB classification system appears to have value as a prognostic indicator, there is no biological basis for the morphologic differences delineated by this system has been identified. Generally, the most important morphologic distinctions are those between ALL and AML5 . Results of patient outcomes in remission were 41 people (82%), drop out 4 people (8%), and died 5 people (10%) due to infection in (1 person), bleeding (1 person), pneumonia (1 person) , and brain edema (1 person). Details are listed in Table 1 . Most of the patient's signs and symptoms at diagnosis pale (78%), fever (64%) with a temperature 38-40 o (60%), temperature >40 o C (4%), no data (20%). In addition, patients also experience other complaints such as bone/joint pain (28%), weakness (28%), gum bleeding (24%), petechiae/purpura (16%). Hepatomegaly (38%), lymphadenopathy (28%), and splenomegaly (26%) in some patients. Details are listed in Figure 1 . Laboratory images at the time of diagnosis were anemia (82%), leukocytosis (38%), and thrombocytopenia (54%) in ALL patients. Details are listed in Table 2 .
Discussion
Based on the results of the study, of the 50 pediatric patients with ALL, male dan female ratio was 1.17, which is in line with a previous study 6. It is stated that male dominance in ALL due to the role of sex hormones in leukemogenesis, but there is still no strong evidence. One recent study in a population with relative genetic homogeneity (the French population of Quebec) demonstrated an increased risk for children with a particular set of glutathione S-transferase (GST) and cytochrome P-450 alleles. A protective effect for female was associated with the presence of a specific P-450 allele. It is suggested that there is an association between a certain HLA-DR haplotype (HLA-DRB4*01) and a particular mutation (C282Y) in the HFE gene (associated with hereditary hemochromatosis) and an increased risk for male developing ALL . 5 Age is a significant prognostic factor in ALL patients. In patients aged 2 -5 years the survival rate is two times greater than patients aged less than 2 years or more than 10 years2. In this study, the incidence of ALL was highest in children aged 1.5-10 years (62%). ALL in infants have a high mortality rate. 5 Most of the 84% (n = 42) families of patients did not have a history of leukemia in the family. However, one patient has a twin with leukemia. Acute leukemia in twin monozygotes is estimated at 25%. The highest risk of twins either mono or heterozygous is in childhood and after 7 years of age . 5 It was believed that the high risk found in ALL twins resulted from blood circulation which was divided prenatally. 7 A total of 21 people (42%) were found with malnutrition at diagnosis. This result is in accordance with the research in Manado during the period 2006-2013, found the frequency of patient with malnutrition as many as 54.8%. On the other hand, results in Yogyakarta showed most of the patients have good nutritional status 29 (69%). Some studies have suggested that nutritional status is a significant prognostic factor. One study showed that malnutrition was a significant predictor of treatment failure. It has also been reported that children who were malnourished will have less tolerance for chemotherapy and received suboptimal doses. 5 Children with ALL usually show symptoms that are not specific so that ALL can look like other diseases. 5 Based on the results of the study, the main complaints felt by patients were pale 78% (n = 39), 64% fever (n = 32), and weak 28% (n = 14). These results are in accordance with research at the Oncology Center of Al-Batool Teaching Hospital in Iraq, as many as 55 patients also had dominant symptoms of fever (81.8%) and pale (67.3%) 8. About 50% of patients present with fever, originating from infection caused by neutropenia or leukemia cells that release cytokines such as interleukin (IL)-1, IL-6, and tumor necrosis factors (TNFs). 3 Laboratory features in leukemic patients vary from mild to severe. In this study, hemoglobin was found to vary between 2.5 g/dl to 13.8 g/dl, with the dominance of 5-10 g/dl Hb of 66% (n = 33). The loss of bone marrow function is due to the progressive infiltration of white blood cells into the bone marrow, thus the bone marrow cannot produce properly.
In addition, in this study, other complaints were found, such as 14 patients with joint pain. Bone pain, especially in the long bones, indicates the involvement of periosteal and bone leukemia. This is due to the presence of bone marrow infiltration by cells from leukemia. One of the factors that caused the occurrence of bone pain in patients, one of which was in the early ALL event the cells in the bone marrow were still normal.
On physical examination results found 38% hepatomegaly (n = 19), 28% lymphadenopathy (n = 14), and 26% splenomegaly (n = 13). Hepatosplenomegaly usually occurs in two thirds of patients and is usually unconscious (asymptomatic). 5 Lymphadenopathy and hepatosplenomegaly arise due to the extramedular invasion of leukemic cells 2. Variations in the infiltration of leukemia cells into organs are related to the time of diagnosis. 6 Hepatomegaly often occurs in patients with hemoglobin <10 g / dl. In diseases that arise more slowly, hepatomegaly is followed by splenomegaly, lymphadenopathy, and hyperleukocytosis. 2 The leukocyte levels in this study varied from 1,300 to 352,000/mm 3 . Eight patients experienced hyperleukocytosis with leukocytes>150,000/mm 3 . Edge blood tests alone cannot be a definitive diagnosis in cases of leukemia. When the results of peripheral blood tests lead to leukemia, then bone marrow examination, immunophenotypes, and cytogenetics must be carried out immediately to make a diagnosis. 6 Our result found 42 patients (84%) with thrombocytopenia, as one of hematopoiesis dysfunction results. Signs and symptoms related to bleeding such as melena, petechiae, bruising, nosebleed, or purpura. The severity and the degree of bleeding correlate with the degree of thrombocytopenia. Severe hemorrhage is rare even with platelet counts less than 20,000 per mm 3 unless fever and infection, both of which can affect platelet survival and function, are present. 5 Anemia, leukocytosis or leukopenia, thrombocytopenia, enlargement of the liver or spleen, bone pain, fever, or a sudden decrease in tolerance to continuation chemotherapy may signal the onset of marrow relapse. 3 From the results of the study, found L1 subtypes 68% (n = 34), L2 18% (n = 9), and L3 0%. L1 subtypes are more common than L2 ALL subtypes6. The Epstein-Barr virus (EBV) has been linked to cases of endemic Burkitt's lymphoma, the L3 morphologic subtype of ALL, and some cases of Hodgkin's disease. L2 subtype is more common in adults. Lymphoblasts of the L3 type possess cell surface immunoglobulin and other characteristic B-cell markers. L1 morphology has been associated with a higher remission induction rate and better event-free survival (EFS) than L2 morphology, which appears to convey a poor prognosis. In early studies, L2 morphology appeared to be an independent prognostic variable indicative of poor outcome. In more recent studies, however, it sometimes loses its predictive value when the patients are stratified for age, sex, and diagnostic white count. Patients with the L3 morphology have the worst overall prognosis. 5 Based on the results of the study, it was found that 54% (n = 27) ALL pediatric patients with standard risk and 46% (n = 23) patients with high risk. Age, gender, and initial leukocyte count are important in prognostic factors. 9 The literature has noted a poor prognostic in children> 10 years and WBC> 50,000/mm 3 . 10 ALL patients with a high risk of dying were twice as large as those of standard risk patients. 2 There were 41 remission patients, 4 patients dropped out, and the rest died. Five patients died from an infection, bleeding, pneumonia, acute pancreatitis, and brain edema. In research, febril neutropenia was the most common complication associated with infection, followed by upper respiratory tract infections, ears, blood flow, and gastrointestinal tract.
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Conclusion
Acute lymphoblastic leukemia in childhood is often found at 1,5-10 of age, male, with no history of leukemia in the family. The most cell morphology sub-type was L1, standard risk ALL, and results in outcome of remission patients. Most symptoms and clinical signs are pale, fever, weak. On physical examination found hepatomegaly, splenomegaly, and lymphadenopathy in 20-40% of patients. Most laboratory examinations of patients with anemia, leukocytosis, and thrombocytopenia.
